Loading…

Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective

Objective  To describe the outcome of pregnancies with fetal and neonatal alloimmune thrombocytopenia (FNAIT) in relation to the invasiveness of the management protocol. Design  Retrospective analysis of prospectively collected data from a national cohort. Setting  Leiden University Medical Centre,...

Full description

Saved in:
Bibliographic Details
Published in:BJOG : an international journal of obstetrics and gynaecology 2007-04, Vol.114 (4), p.469-473
Main Authors: Van Den Akker, ESA, Oepkes, D, Lopriore, E, Brand, A, Kanhai, HHH
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4554-ace5a09dd907b4a4029d40be4a4a2d96a5aa8b24a10da3e356fdd5878ba638543
cites cdi_FETCH-LOGICAL-c4554-ace5a09dd907b4a4029d40be4a4a2d96a5aa8b24a10da3e356fdd5878ba638543
container_end_page 473
container_issue 4
container_start_page 469
container_title BJOG : an international journal of obstetrics and gynaecology
container_volume 114
creator Van Den Akker, ESA
Oepkes, D
Lopriore, E
Brand, A
Kanhai, HHH
description Objective  To describe the outcome of pregnancies with fetal and neonatal alloimmune thrombocytopenia (FNAIT) in relation to the invasiveness of the management protocol. Design  Retrospective analysis of prospectively collected data from a national cohort. Setting  Leiden University Medical Centre, the national centre for management of severe red cell and platelet alloimmunisation in pregnancy. Population  Ninety‐eight pregnancies in 85 women with FNAIT having a previous child with thrombocytopenia with (n= 16) or without (n= 82) an intracranial haemorrhage (ICH). Methods  Our management protocol evolved over time from (1) serial fetal blood samplings (FBS) and platelet transfusion (n= 13) via (2) combined FBS with maternal intravenous immunoglobulins (n= 33) to (3) completely noninvasive treatment with immunoglobulins only (n= 52 pregnancies, resulting in 53 neonates). Perinatal outcome was assessed according to the three types of management. Main outcome measures  Occurrence of ICH, perinatal survival, gestational age at birth and complications of FBS. Results  All but one of 98 pregnancies ended in a live birth; none of the neonates had an ICH. The median gestational age at birth was 37 weeks (range 32–40). In groups 1 and 2, three emergency caesarean sections were performed after complicated FBS, resulting in two healthy babies and one neonatal death. Conclusion  Noninvasive antenatal management of pregnancies complicated by FNAIT appears to be both effective and safe.
doi_str_mv 10.1111/j.1471-0528.2007.01244.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70301441</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70301441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4554-ace5a09dd907b4a4029d40be4a4a2d96a5aa8b24a10da3e356fdd5878ba638543</originalsourceid><addsrcrecordid>eNqN0U1v1DAQBmALUdFS-AsoQoJb0vFX4iBxgIqvqqIXOFuTZAxZJfYSJ6X773F2V1TiQn3xyH48GutlLONQ8LQuNgVXFc9BC1MIgKoALpQq7h6xs78Xj_c15CCFOWVPY9wA8FKAfMJOeSWh1kqfMfc1-N7fYuxvKUM_k8cZh2xEjz9oJD9nwWWO1jP0XeYpHAAOQ-jHcfGUzT-nMDah3c1hS77HN1lER3tOzlE7p9bP2InDIdLz437Ovn_88O3yc3598-nL5bvrvFVaqxxb0gh119VQNQoViLpT0FAqUXR1iRrRNEIhhw4lSV26rtOmMg2W0mglz9nrQ9_tFH4tFGc79rGlYcA0-RJtBRK4Uvy_UEBSRtQJvvwHbsIy-fQJK4QuuSjLMiFzQO0UYpzI2e3UjzjtLAe7JmY3dg3GrsHYNTG7T8zepacvjv2XZqTu_uExogReHQHGFgc3oW_7eO-MNoZLmdzbg_vdD7R78AD2_dXNWsk_8Dix8g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>225612666</pqid></control><display><type>article</type><title>Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Van Den Akker, ESA ; Oepkes, D ; Lopriore, E ; Brand, A ; Kanhai, HHH</creator><creatorcontrib>Van Den Akker, ESA ; Oepkes, D ; Lopriore, E ; Brand, A ; Kanhai, HHH</creatorcontrib><description>Objective  To describe the outcome of pregnancies with fetal and neonatal alloimmune thrombocytopenia (FNAIT) in relation to the invasiveness of the management protocol. Design  Retrospective analysis of prospectively collected data from a national cohort. Setting  Leiden University Medical Centre, the national centre for management of severe red cell and platelet alloimmunisation in pregnancy. Population  Ninety‐eight pregnancies in 85 women with FNAIT having a previous child with thrombocytopenia with (n= 16) or without (n= 82) an intracranial haemorrhage (ICH). Methods  Our management protocol evolved over time from (1) serial fetal blood samplings (FBS) and platelet transfusion (n= 13) via (2) combined FBS with maternal intravenous immunoglobulins (n= 33) to (3) completely noninvasive treatment with immunoglobulins only (n= 52 pregnancies, resulting in 53 neonates). Perinatal outcome was assessed according to the three types of management. Main outcome measures  Occurrence of ICH, perinatal survival, gestational age at birth and complications of FBS. Results  All but one of 98 pregnancies ended in a live birth; none of the neonates had an ICH. The median gestational age at birth was 37 weeks (range 32–40). In groups 1 and 2, three emergency caesarean sections were performed after complicated FBS, resulting in two healthy babies and one neonatal death. Conclusion  Noninvasive antenatal management of pregnancies complicated by FNAIT appears to be both effective and safe.</description><identifier>ISSN: 1470-0328</identifier><identifier>EISSN: 1471-0528</identifier><identifier>DOI: 10.1111/j.1471-0528.2007.01244.x</identifier><identifier>PMID: 17309545</identifier><identifier>CODEN: BIOGFQ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Alloimmune thrombocytopenia ; Antibodies - blood ; Antigens, Human Platelet - immunology ; Biological and medical sciences ; Blood tests ; Female ; fetal blood sampling ; Fetal Diseases - therapy ; Gestational Age ; Gynecology. Andrology. Obstetrics ; Hematologic and hematopoietic diseases ; HPA‐1a ; Humans ; Infant, Newborn ; intracranial haemorrhage ; intravenous immunoglobulins ; Medical sciences ; Neonatal care ; noninvasive treatment ; Obstetrics ; Platelet diseases and coagulopathies ; Platelet Transfusion ; Pregnancy ; Pregnancy Outcome ; Prenatal care ; Prenatal Care - methods ; Prospective Studies ; Retrospective Studies ; Thrombocytopenia - embryology ; Thrombocytopenia - therapy</subject><ispartof>BJOG : an international journal of obstetrics and gynaecology, 2007-04, Vol.114 (4), p.469-473</ispartof><rights>RCOG 2007 BJOG An International Journal of Obstetrics and Gynaecology</rights><rights>2007 INIST-CNRS</rights><rights>2007 The Authors Journal compilation</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4554-ace5a09dd907b4a4029d40be4a4a2d96a5aa8b24a10da3e356fdd5878ba638543</citedby><cites>FETCH-LOGICAL-c4554-ace5a09dd907b4a4029d40be4a4a2d96a5aa8b24a10da3e356fdd5878ba638543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18588133$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17309545$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Van Den Akker, ESA</creatorcontrib><creatorcontrib>Oepkes, D</creatorcontrib><creatorcontrib>Lopriore, E</creatorcontrib><creatorcontrib>Brand, A</creatorcontrib><creatorcontrib>Kanhai, HHH</creatorcontrib><title>Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective</title><title>BJOG : an international journal of obstetrics and gynaecology</title><addtitle>BJOG</addtitle><description>Objective  To describe the outcome of pregnancies with fetal and neonatal alloimmune thrombocytopenia (FNAIT) in relation to the invasiveness of the management protocol. Design  Retrospective analysis of prospectively collected data from a national cohort. Setting  Leiden University Medical Centre, the national centre for management of severe red cell and platelet alloimmunisation in pregnancy. Population  Ninety‐eight pregnancies in 85 women with FNAIT having a previous child with thrombocytopenia with (n= 16) or without (n= 82) an intracranial haemorrhage (ICH). Methods  Our management protocol evolved over time from (1) serial fetal blood samplings (FBS) and platelet transfusion (n= 13) via (2) combined FBS with maternal intravenous immunoglobulins (n= 33) to (3) completely noninvasive treatment with immunoglobulins only (n= 52 pregnancies, resulting in 53 neonates). Perinatal outcome was assessed according to the three types of management. Main outcome measures  Occurrence of ICH, perinatal survival, gestational age at birth and complications of FBS. Results  All but one of 98 pregnancies ended in a live birth; none of the neonates had an ICH. The median gestational age at birth was 37 weeks (range 32–40). In groups 1 and 2, three emergency caesarean sections were performed after complicated FBS, resulting in two healthy babies and one neonatal death. Conclusion  Noninvasive antenatal management of pregnancies complicated by FNAIT appears to be both effective and safe.</description><subject>Alloimmune thrombocytopenia</subject><subject>Antibodies - blood</subject><subject>Antigens, Human Platelet - immunology</subject><subject>Biological and medical sciences</subject><subject>Blood tests</subject><subject>Female</subject><subject>fetal blood sampling</subject><subject>Fetal Diseases - therapy</subject><subject>Gestational Age</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Hematologic and hematopoietic diseases</subject><subject>HPA‐1a</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>intracranial haemorrhage</subject><subject>intravenous immunoglobulins</subject><subject>Medical sciences</subject><subject>Neonatal care</subject><subject>noninvasive treatment</subject><subject>Obstetrics</subject><subject>Platelet diseases and coagulopathies</subject><subject>Platelet Transfusion</subject><subject>Pregnancy</subject><subject>Pregnancy Outcome</subject><subject>Prenatal care</subject><subject>Prenatal Care - methods</subject><subject>Prospective Studies</subject><subject>Retrospective Studies</subject><subject>Thrombocytopenia - embryology</subject><subject>Thrombocytopenia - therapy</subject><issn>1470-0328</issn><issn>1471-0528</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqN0U1v1DAQBmALUdFS-AsoQoJb0vFX4iBxgIqvqqIXOFuTZAxZJfYSJ6X773F2V1TiQn3xyH48GutlLONQ8LQuNgVXFc9BC1MIgKoALpQq7h6xs78Xj_c15CCFOWVPY9wA8FKAfMJOeSWh1kqfMfc1-N7fYuxvKUM_k8cZh2xEjz9oJD9nwWWO1jP0XeYpHAAOQ-jHcfGUzT-nMDah3c1hS77HN1lER3tOzlE7p9bP2InDIdLz437Ovn_88O3yc3598-nL5bvrvFVaqxxb0gh119VQNQoViLpT0FAqUXR1iRrRNEIhhw4lSV26rtOmMg2W0mglz9nrQ9_tFH4tFGc79rGlYcA0-RJtBRK4Uvy_UEBSRtQJvvwHbsIy-fQJK4QuuSjLMiFzQO0UYpzI2e3UjzjtLAe7JmY3dg3GrsHYNTG7T8zepacvjv2XZqTu_uExogReHQHGFgc3oW_7eO-MNoZLmdzbg_vdD7R78AD2_dXNWsk_8Dix8g</recordid><startdate>200704</startdate><enddate>200704</enddate><creator>Van Den Akker, ESA</creator><creator>Oepkes, D</creator><creator>Lopriore, E</creator><creator>Brand, A</creator><creator>Kanhai, HHH</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><general>Wiley Subscription Services, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200704</creationdate><title>Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective</title><author>Van Den Akker, ESA ; Oepkes, D ; Lopriore, E ; Brand, A ; Kanhai, HHH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4554-ace5a09dd907b4a4029d40be4a4a2d96a5aa8b24a10da3e356fdd5878ba638543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Alloimmune thrombocytopenia</topic><topic>Antibodies - blood</topic><topic>Antigens, Human Platelet - immunology</topic><topic>Biological and medical sciences</topic><topic>Blood tests</topic><topic>Female</topic><topic>fetal blood sampling</topic><topic>Fetal Diseases - therapy</topic><topic>Gestational Age</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Hematologic and hematopoietic diseases</topic><topic>HPA‐1a</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>intracranial haemorrhage</topic><topic>intravenous immunoglobulins</topic><topic>Medical sciences</topic><topic>Neonatal care</topic><topic>noninvasive treatment</topic><topic>Obstetrics</topic><topic>Platelet diseases and coagulopathies</topic><topic>Platelet Transfusion</topic><topic>Pregnancy</topic><topic>Pregnancy Outcome</topic><topic>Prenatal care</topic><topic>Prenatal Care - methods</topic><topic>Prospective Studies</topic><topic>Retrospective Studies</topic><topic>Thrombocytopenia - embryology</topic><topic>Thrombocytopenia - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van Den Akker, ESA</creatorcontrib><creatorcontrib>Oepkes, D</creatorcontrib><creatorcontrib>Lopriore, E</creatorcontrib><creatorcontrib>Brand, A</creatorcontrib><creatorcontrib>Kanhai, HHH</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>BJOG : an international journal of obstetrics and gynaecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van Den Akker, ESA</au><au>Oepkes, D</au><au>Lopriore, E</au><au>Brand, A</au><au>Kanhai, HHH</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective</atitle><jtitle>BJOG : an international journal of obstetrics and gynaecology</jtitle><addtitle>BJOG</addtitle><date>2007-04</date><risdate>2007</risdate><volume>114</volume><issue>4</issue><spage>469</spage><epage>473</epage><pages>469-473</pages><issn>1470-0328</issn><eissn>1471-0528</eissn><coden>BIOGFQ</coden><abstract>Objective  To describe the outcome of pregnancies with fetal and neonatal alloimmune thrombocytopenia (FNAIT) in relation to the invasiveness of the management protocol. Design  Retrospective analysis of prospectively collected data from a national cohort. Setting  Leiden University Medical Centre, the national centre for management of severe red cell and platelet alloimmunisation in pregnancy. Population  Ninety‐eight pregnancies in 85 women with FNAIT having a previous child with thrombocytopenia with (n= 16) or without (n= 82) an intracranial haemorrhage (ICH). Methods  Our management protocol evolved over time from (1) serial fetal blood samplings (FBS) and platelet transfusion (n= 13) via (2) combined FBS with maternal intravenous immunoglobulins (n= 33) to (3) completely noninvasive treatment with immunoglobulins only (n= 52 pregnancies, resulting in 53 neonates). Perinatal outcome was assessed according to the three types of management. Main outcome measures  Occurrence of ICH, perinatal survival, gestational age at birth and complications of FBS. Results  All but one of 98 pregnancies ended in a live birth; none of the neonates had an ICH. The median gestational age at birth was 37 weeks (range 32–40). In groups 1 and 2, three emergency caesarean sections were performed after complicated FBS, resulting in two healthy babies and one neonatal death. Conclusion  Noninvasive antenatal management of pregnancies complicated by FNAIT appears to be both effective and safe.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17309545</pmid><doi>10.1111/j.1471-0528.2007.01244.x</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1470-0328
ispartof BJOG : an international journal of obstetrics and gynaecology, 2007-04, Vol.114 (4), p.469-473
issn 1470-0328
1471-0528
language eng
recordid cdi_proquest_miscellaneous_70301441
source Wiley-Blackwell Read & Publish Collection
subjects Alloimmune thrombocytopenia
Antibodies - blood
Antigens, Human Platelet - immunology
Biological and medical sciences
Blood tests
Female
fetal blood sampling
Fetal Diseases - therapy
Gestational Age
Gynecology. Andrology. Obstetrics
Hematologic and hematopoietic diseases
HPA‐1a
Humans
Infant, Newborn
intracranial haemorrhage
intravenous immunoglobulins
Medical sciences
Neonatal care
noninvasive treatment
Obstetrics
Platelet diseases and coagulopathies
Platelet Transfusion
Pregnancy
Pregnancy Outcome
Prenatal care
Prenatal Care - methods
Prospective Studies
Retrospective Studies
Thrombocytopenia - embryology
Thrombocytopenia - therapy
title Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T09%3A58%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Noninvasive%20antenatal%20management%20of%20fetal%20and%20neonatal%20alloimmune%20thrombocytopenia:%20safe%20and%20effective&rft.jtitle=BJOG%20:%20an%20international%20journal%20of%20obstetrics%20and%20gynaecology&rft.au=Van%20Den%20Akker,%20ESA&rft.date=2007-04&rft.volume=114&rft.issue=4&rft.spage=469&rft.epage=473&rft.pages=469-473&rft.issn=1470-0328&rft.eissn=1471-0528&rft.coden=BIOGFQ&rft_id=info:doi/10.1111/j.1471-0528.2007.01244.x&rft_dat=%3Cproquest_cross%3E70301441%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4554-ace5a09dd907b4a4029d40be4a4a2d96a5aa8b24a10da3e356fdd5878ba638543%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=225612666&rft_id=info:pmid/17309545&rfr_iscdi=true